According to a recent study, medications frequently prescribed to patients to reduce joint inflammation may also lessen the risk of cardiovascular disease in those with rheumatoid arthritis, who are at an elevated risk for the condition.
Geneva [Switzerland], January 14 (ANI): The World Health Organization (WHO) Guideline Development Group recommended the use of two arthritis drugs called baricitinib and interleukin-6 (IL-6) in combination with corticosteroids to treat patients with severe or critical COVID-19, on Friday.